Snowball logo
logo
TVTX

Travere Therapeutics Inc

TVTX β€’ NASDAQ
$62.76-$1.98Β  (3.06%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
131.8109.5145.2233.2490.7591.3
COGS
3.8184.4211.457.74410.3433.08
Gross Profit
128105133.8225.4480.4558.3
Operating Expenses & Income
Operating Income
(199.4)(319.8)(388.1)(323.8)(62.82)(40.46)
Total Operating Expenses
327.4424.9521.9549.3543.2598.7
R&D Expenses
201.2227.3245282.7206227.1
Selling General & Admin Expenses
126.3197.5265.5264.1337.2364.5
Earnings from Continuing Operations
Interest Expense
(19.68)(11.01)(11.33)(11.18)(10.75)(9.481)
Interest Income
1.9936.27621.7717.8212.7211.58
Income Tax Expense
0.4090.3130.2230.120.9880.605
Net Income
Net Income
(180.1)(278.5)(111.4)(321.5)(25.55)(43.46)
Supplemental
EBIT
(197.2)(320.1)(364.8)(309.3)(38.52)-
EBITDA
(184.5)(299.4)(326.2)(265.8)22.221.544
In millions of USD, except % and values per 1 share